Madison Fund Sold Globus Medical (GMED) as Valuation Exceeded

Madison Small Cap Fund liquidated its position in Globus Medical, Inc. (GMED) after a multi-year investment, citing a market cap increase to $12 billion and a share price of $90 compared to their intrinsic value estimate of $85. GMED shares closed at $80.52 on June 11, 2026, with a one-month return of 5.06% and a 36.71% increase over the past year. For Q1 2026, GMED reported revenue of $759.9 million, reflecting a year-over-year growth of 27%. Despite its potential, the fund expressed a preference for smaller investment alternatives amid AI stock opportunities.